This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
English to Afrikaans: Participant Card General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - English This participant is taking part in a blinded, placebo-controlled study in which the investigational drug, relugolix, a GnRH antagonist, is being investigated with co-adminstration of estradiol and norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids.
FOR HEALTHCARE PROFESSIONALS:
In case of a medical emergency involving this participant, please contact the study doctor for information about the study medication and this patient’s participation in the study (contact information on the back of this card).
Translation - Afrikaans Hierdie deelnemer neem deel aan 'n blinde, plasebo-gekontroleerde studie waarin die navorsingsmiddel, relugoliks, 'n GnRH-antagonis, ondersoek word wat saam met estradiol en noretindroon-asetaat toegedien word vir die behandeling van swaar menstruele bloeding geassosieer met baarmoederfibroïede.
VIR MEDIESE BEROEPSLUI:
Indien hierdie deelnemer ’n mediese noodgeval ervaar, kontak asseblief die studiedokter vir inligting oor die studiemedikasie en hierdie pasiënt se deelname aan die studie (kontakinligting agterop hierdie kaart).
English to Afrikaans: South African Informed Consent Document General field: Medical Detailed field: Medical: Pharmaceuticals
Source text - English PARTICIPANT INFORMATION AND INFORMED CONSENT DOCUMENT
Study Title: An International Phase 3 Double-Blind, Placebo-controlled, Randomized Withdrawal Study of Relugolix Co-administered with Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids
The purpose of this study is to test the long-term effectiveness and safety of the investigational study drug, relugolix, co-administered with estradiol (oestrogen) and norethindrone acetate (progesterone) to treat your condition, uterine fibroids and heavy menstrual bleeding.
The use of oestrogen and progesterone medication has been approved by several government health authorities as replacement hormone therapy to prevent bone loss.
The use of estradiol (oestrogen) and norethindrone acetate (progesterone) with relugolix to treat participants with heavy menstrual bleeding associated with uterine fibroids is investigational.
Translation - Afrikaans INLIGTING- EN INGELIGTETOESTEMMINGSDOKUMENT VIR DEELNEMERS
Studietitel: ’n Internasionale fase 3-, dubbelblinde, plasebogekontroleerde, verewekansigde onttrekkingstudie om relugoliks te evalueer wat saam met estradiol en noretindroonasetaat toegedien word by vroue met swaar menstruele bloeding wat met baarmoederfibroïede geassosieer word
Die doel van hierdie studie is om te toets hoe doeltreffend en veilig die navorsingstudiemedikasie, relugoliks, is wanneer dit saam met estradiol (estrogeen) en noretindroonasetaat (progesteroon) toegedien word om u toestand, baarmoederfibroïede met swaar menstruele bloeding, te behandel.
Die gebruik van estrogeen- en progesteroonmedikasie is deur verskeie regeringsgesondheidsowerhede as 'n plaasvervanger-hormoonterapie goedgekeur om beenverlies te voorkom.
Die gebruik van estradiol (estrogeen) en noretindroonasetaat (progesteroon) saam met relugoliks om deelnemers met swaar menstruele bloeding wat met baarmoederfibroïede geassosieer word, te behandel, is van ’n navorsingsaard.
Afrikaans to English: Personnel Policy - Annexure 2: HIV/AIDS Policy General field: Law/Patents Detailed field: Real Estate
Source text - Afrikaans 1. Inleiding
Die werkgewer is daartoe verbind om ‘n gesonde werksomgewing te handhaaf deur die fisieke en geestelike gesondheid en welsyn van alle werknemers in die werksplek te beskerm. Die werknemer erken die erns van die Menslike Immuniteitsgebrek Virus (MIV) en Verworwe Immuniteitsgebrek Sindroom (VIGS) pandemie en die potensiële impak wat hierdie siekte op beide die werkgewer en die breër samelewing kan hê en is daartoe verbind om aktief deel te neem aan die stryd teen die siekte.
Persone wat met MIV en VIGS geïnfekteer is en daardeur geaffekteer word, het die reg op waardigheid, respek en privaatheid wat betref hul MIV- en VIGS-status.
Persone wat met MIV en VIGS saamleef word gelyke beskerming onder die wet gewaarborg en daar sal nie teen hulle gediskrimineer word in die verkryging van werk en werksvoordele by `n werkgewer op grond van MIV en VIGS alleen nie.
Die werkgewer sal, binne sy fondse vir die doel geoormerk, poog om sover moontlik toegang tot inligtings-, voorkomings-, versorgings- en ondersteuningsdienste vir personeel wat met MIV en VIGS geïnfekteer en daardeur geaffekteer is, te verskaf.
Die werkgewer het die plig om ‘n werksomgewing te skep wat ondersteunend, sensitief en simpatiek is teenoor werknemers wat deur MIV en VIGS geïnfekteer is of geaffekteer word.
Translation - English 1. Introduction
The employer is committed to maintaining a healthy work environment by protecting the physical and mental health of all employees. The employer acknowledges the severity of the Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) pandemic and the potential impact this disease can have on both the employer and the broader society and is committed to actively take part in the fight against this disease.
Persons who have been infected with HIV and AIDS and are affected by it have the right to dignity, respect and privacy regarding their HIV and AIDS status.
Persons living with HIV and AIDS are guaranteed equal protection under the law and will not be discriminated against with regards to employment and employment benefits by an employer on the grounds of HIV and AIDS alone.
The employer will, within the limits of their funding for the purpose thereof and to the extent possible, attempt to provide access to information services, prevention, and support services to personnel infected with and affected by HIV and AIDS.
It is the duty of the employer to create a working environment that is supportive, sensitive, and sympathetic toward employees infected with or affected by HIV and AIDS.
More
Less
Translation education
University of the Free State
Experience
Years of experience: 8. Registered at ProZ.com: Mar 2016.
Afrikaans to English (University of the Free State) Afrikaans to English (University of the Free State)
Memberships
N/A
Software
Adobe Acrobat, Crowdin, Google Translator Toolkit, MateCat, memoQ, MemSource Cloud, Microsoft Excel, Microsoft Word, ATMS, Jira, Workday, XLiff, STAR Transit, Trados Online Editor, Trados Studio
Learn more about additional services I can provide my clients
Stay up to date on what is happening in the language industry
Buy or learn new work-related software
Bio
Working as a
linguist requires a very specific set of skills, these skills include the
ability to analyse and correctly interpret the client's brief, very strong
language skills in order to provide a translation, localization or
proofreading task that is of the highest standard, a meticulous eye for
detail, and the ability to work efficiently in order to meet deadlines. These
are skills that I have honed during years working as a freelance linguist and
further improved by obtaining my Master’s Degree in Language Practice.
My experience includes translating and proofreading a variety of texts from
English to Afrikaans including academic, corporate and technical texts
comprising of IT related texts as well as medical texts. I believe that while
it is possible to become an expert in a certain field, a person should never
stop learning and always strive to be better.
Expertise